155 related articles for article (PubMed ID: 33074339)
1. Incidence of Kaposi Sarcoma in Sweden is Decreasing.
Bieliauskiene G; Zaar O; Kolmodin I; Gillstedt M; Paoli J
Acta Derm Venereol; 2020 Oct; 100(17):adv00305. PubMed ID: 33074339
[TBL] [Abstract][Full Text] [Related]
2. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.
Lodi S; Guiguet M; Costagliola D; Fisher M; de Luca A; Porter K;
J Natl Cancer Inst; 2010 Jun; 102(11):784-92. PubMed ID: 20442214
[TBL] [Abstract][Full Text] [Related]
3. The impact of the South African antiretroviral treatment programme on the age-standardised incidence rate of Kaposi sarcoma, 1999-2016: An interrupted time series analysis.
Majaya E; Girdler-Brown BV; Muchengeti M; Singh E
Int J Infect Dis; 2021 Jan; 102():20-27. PubMed ID: 33065295
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence of Kaposi sarcoma in Sweden before the AIDS epidemic.
Bendsöe N; Dictor M; Blomberg J; Agren S; Merk K
Eur J Cancer; 1990; 26(6):699-702. PubMed ID: 2144157
[TBL] [Abstract][Full Text] [Related]
5. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
6. Extracutaneous Kaposi sarcoma risk remains higher in people with HIV in the post-ART era.
Dinh S; Malmström S; Möller IK; Yilmaz A; Svedhem V; Carlander C
AIDS; 2023 Nov; 37(13):2041-2048. PubMed ID: 37451428
[TBL] [Abstract][Full Text] [Related]
7. Kaposi Sarcoma with Mucocutaneous Involvement in French Guiana: An Epidemiological Study between 1969 and 2019.
Lamoureux C; Drak Alsibai K; Pradinaud R; Sainte-Marie D; Couppie P; Blaizot R
Acta Derm Venereol; 2022 May; 102():adv00709. PubMed ID: 35199178
[TBL] [Abstract][Full Text] [Related]
8. Risk of Nonkeratinocyte Skin Cancers in People Living with HIV during the Era of Antiretroviral Therapy.
Luu YT; Luo Q; Horner MJ; Shiels M; Engels EA; Sargen MR
J Invest Dermatol; 2023 Apr; 143(4):588-595.e3. PubMed ID: 36216206
[TBL] [Abstract][Full Text] [Related]
9. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
[TBL] [Abstract][Full Text] [Related]
10. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project.
Stiller CA; Trama A; Brewster DH; Verne J; Bouchardy C; Navarro C; Chirlaque MD; Marcos-Gragera R; Visser O; Serraino D; Weiderpass E; Dei Tos AP; Ascoli V;
Cancer Epidemiol; 2014 Dec; 38(6):670-8. PubMed ID: 25454979
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
13. Global patterns and trends in Kaposi sarcoma incidence: a population-based study.
Fu L; Tian T; Wang B; Lu Z; Gao Y; Sun Y; Lin YF; Zhang W; Li Y; Zou H
Lancet Glob Health; 2023 Oct; 11(10):e1566-e1575. PubMed ID: 37734800
[TBL] [Abstract][Full Text] [Related]
14. Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.
White DL; Oluyomi A; Royse K; Dong Y; Nguyen H; Chang E; Richardson P; Jiao L; Garcia JM; Kramer JR; Thrift AP; Chiao E
J Acquir Immune Defic Syndr; 2019 Aug; 81(4):387-394. PubMed ID: 31242141
[TBL] [Abstract][Full Text] [Related]
15. Kaposi sarcoma incidence in Mozambique: national and regional estimates.
Meireles P; Albuquerque G; Vieira M; Foia S; Ferro J; Carrilho C; Lunet N
Eur J Cancer Prev; 2015 Nov; 24(6):529-34. PubMed ID: 25494288
[TBL] [Abstract][Full Text] [Related]
16. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
[TBL] [Abstract][Full Text] [Related]
17. Risk of Kaposi sarcoma among immigrants to Sweden.
Mousavi SM; Sundquist J; Hemminki K
Acta Derm Venereol; 2014 Jul; 94(4):476-7. PubMed ID: 24212288
[No Abstract] [Full Text] [Related]
18. Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome.
Dictor M; Attewell R
Int J Cancer; 1988 Sep; 42(3):346-51. PubMed ID: 3417362
[TBL] [Abstract][Full Text] [Related]
19. Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?
Chaabna K; Bray F; Wabinga HR; Chokunonga E; Borok M; Vanhems P; Forman D; Soerjomataram I
Int J Cancer; 2013 Sep; 133(5):1197-203. PubMed ID: 23436712
[TBL] [Abstract][Full Text] [Related]
20. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
